Miller Matthew K, Chapa-Villarreal Fabiola A, Oldenkamp Heidi F, Elder Michael G, Venkataraman Abhijeet K, Peppas Nicholas A
McKetta Department of Chemical Engineering, 200 E. Dean Keeton St. Stop C0400, Austin, TX 78712, USA; Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, 107 W Dean Keeton Street Stop C0800, Austin, TX, USA, 78712.
Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, 107 W Dean Keeton Street Stop C0800, Austin, TX, USA, 78712; Department of Biomedical Engineering, The University of Texas at Austin, 107 W Dean Keeton Street Stop C0800, Austin, TX 78712, USA.
J Control Release. 2023 Sep;361:246-259. doi: 10.1016/j.jconrel.2023.07.044. Epub 2023 Aug 8.
Currently, commercially available antibody therapies must be delivered via parenteral administration. Oral delivery of antibodies could increase patient compliance and improve quality of life, however there is currently no viable system for delivering antibodies orally. In this work, a self-assembled, pH-responsive nanoparticle delivery system was developed to load and deliver antibodies via the oral route. The nanoparticles were synthesized via nanoprecipitation using the pH-responsive copolymers based on poly(methacrylic acid-co-methyl methacrylate)-block-poly(ethylene glycol). The reversibly hydrophobic nature of this polymer allowed it to function as an antibody delivery system via self-assembly. Characteristics of the polymer, including monomer ratios and molecular weight, as well as parameters of the nanoprecipitation process were optimized using Design of Experiments to achieve nanoparticles with desired size, polydispersity, loading efficiency, and release characteristics. Ultimately, the synthesized and optimized nanoparticles exhibited a hydrodynamic size within a range that avoids premature clearance, a low polydispersity index, and high IgG loading efficiency. In in vitro antibody release studies at physiologically relevant pH values, the nanoparticles exhibit promising release profiles. The nanoparticles presented in this work show potential as oral delivery vehicles for therapeutic antibodies.
目前,市售的抗体疗法必须通过肠胃外给药。抗体的口服给药可以提高患者的依从性并改善生活质量,然而目前尚无可行的口服抗体递送系统。在这项工作中,开发了一种自组装的、pH响应性纳米颗粒递送系统,用于通过口服途径装载和递送抗体。使用基于聚(甲基丙烯酸-co-甲基丙烯酸甲酯)-嵌段-聚(乙二醇)的pH响应性共聚物,通过纳米沉淀法合成纳米颗粒。这种聚合物的可逆疏水性使其能够通过自组装作为抗体递送系统发挥作用。利用实验设计优化了聚合物的特性,包括单体比例和分子量,以及纳米沉淀过程的参数,以获得具有所需尺寸、多分散性、负载效率和释放特性的纳米颗粒。最终,合成并优化后的纳米颗粒表现出的流体动力学尺寸在避免过早清除的范围内,多分散指数低,IgG负载效率高。在生理相关pH值下的体外抗体释放研究中,纳米颗粒呈现出有前景的释放曲线。这项工作中展示的纳米颗粒显示出作为治疗性抗体口服递送载体的潜力。